NASDAQ · Key Statistics
Bambusa Therapeutics Inc. (BBTX) P/E Ratio, ROE & Key Statistics
$16.24
NASDAQ: BBTX
Market Cap $808.25M
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Bambusa Therapeutics Inc. (BBTX), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Profitability
Financial health
Per share and size
Bambusa Therapeutics Inc. (BBTX) statistics — frequently asked questions
How much debt does Bambusa Therapeutics Inc. carry?
Bambusa Therapeutics Inc. (BBTX) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.
P/E and ROE of other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.